JP2019524090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524090A5 JP2019524090A5 JP2019500531A JP2019500531A JP2019524090A5 JP 2019524090 A5 JP2019524090 A5 JP 2019524090A5 JP 2019500531 A JP2019500531 A JP 2019500531A JP 2019500531 A JP2019500531 A JP 2019500531A JP 2019524090 A5 JP2019524090 A5 JP 2019524090A5
- Authority
- JP
- Japan
- Prior art keywords
- rdh12
- composition
- functional
- nucleic acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000742938 Homo sapiens Retinol dehydrogenase 12 Proteins 0.000 claims 22
- 102100038054 Retinol dehydrogenase 12 Human genes 0.000 claims 20
- 150000007523 nucleic acids Chemical group 0.000 claims 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 6
- 210000000234 capsid Anatomy 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 210000000608 photoreceptor cell Anatomy 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 108090000565 Capsid Proteins Proteins 0.000 claims 2
- 102100023321 Ceruloplasmin Human genes 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 2
- 241000702421 Dependoparvovirus Species 0.000 claims 2
- 201000010480 Leber congenital amaurosis 13 Diseases 0.000 claims 2
- 208000036575 RDH12-related recessive retinopathy Diseases 0.000 claims 2
- 208000030533 eye disease Diseases 0.000 claims 2
- 102000046986 human RDH12 Human genes 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 108091008695 photoreceptors Proteins 0.000 claims 2
- 239000013612 plasmid Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims 1
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims 1
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims 1
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims 1
- 201000004569 Blindness Diseases 0.000 claims 1
- 201000003533 Leber congenital amaurosis Diseases 0.000 claims 1
- 101150033365 Rdh12 gene Proteins 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 238000003205 genotyping method Methods 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001566 pro-viral effect Effects 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000002207 retinal effect Effects 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 230000004393 visual impairment Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022076693A JP7572990B2 (ja) | 2016-07-08 | 2022-05-06 | Ｒｄｈ１２が関与する疾患及び疾病を治療する方法及び組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662359777P | 2016-07-08 | 2016-07-08 | |
| US62/359,777 | 2016-07-08 | ||
| PCT/US2017/041122 WO2018009814A1 (en) | 2016-07-08 | 2017-07-07 | Methods and compositions for treatment of disorders and diseases involving rdh12 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022076693A Division JP7572990B2 (ja) | 2016-07-08 | 2022-05-06 | Ｒｄｈ１２が関与する疾患及び疾病を治療する方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524090A JP2019524090A (ja) | 2019-09-05 |
| JP2019524090A5 true JP2019524090A5 (OSRAM) | 2020-07-16 |
| JP7101656B2 JP7101656B2 (ja) | 2022-07-15 |
Family
ID=60901399
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019500531A Active JP7101656B2 (ja) | 2016-07-08 | 2017-07-07 | Ｒｄｈ１２が関与する疾患及び疾病を治療する方法及び組成物 |
| JP2022076693A Active JP7572990B2 (ja) | 2016-07-08 | 2022-05-06 | Ｒｄｈ１２が関与する疾患及び疾病を治療する方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022076693A Active JP7572990B2 (ja) | 2016-07-08 | 2022-05-06 | Ｒｄｈ１２が関与する疾患及び疾病を治療する方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11197936B2 (OSRAM) |
| EP (1) | EP3481958A4 (OSRAM) |
| JP (2) | JP7101656B2 (OSRAM) |
| KR (2) | KR102526506B1 (OSRAM) |
| CN (1) | CN110191954B (OSRAM) |
| AU (2) | AU2017292010B2 (OSRAM) |
| BR (1) | BR112019000171A2 (OSRAM) |
| CA (1) | CA3029646A1 (OSRAM) |
| IL (3) | IL264070B2 (OSRAM) |
| RU (1) | RU2764920C2 (OSRAM) |
| WO (1) | WO2018009814A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL258024B2 (en) * | 2015-09-24 | 2023-03-01 | Univ Pennsylvania | A preparation and method for the treatment of a complement-mediated disease |
| IL264070B2 (en) | 2016-07-08 | 2023-03-01 | Univ Pennsylvania | Methods and preparations for the treatment of disorders and diseases involving rdh12 |
| EP3619019A4 (en) | 2017-05-04 | 2021-01-20 | Lehigh University | ADDITIVE MANUFACTURING SYSTEM WITH ADJUSTABLE MATERIAL PROPERTIES |
| WO2019099696A1 (en) | 2017-11-15 | 2019-05-23 | The Regents Of The University Of Michigan | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies |
| CA3209779A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| TR2021022284A2 (tr) * | 2021-12-31 | 2022-01-21 | T C Ueskuedar Ueniversitesi | Retinitis pigmentosa (rp) hastalığının tedavisinde kullanılmak üzere retinol dehidrojenaz 12 (rdh12) gen mutasyonlarına yönelik crıspr-pe sistemi. |
| CN115725659A (zh) * | 2022-04-01 | 2023-03-03 | 首都医科大学附属北京同仁医院 | 一种应用视网膜原位基因编辑制作非人灵长类动物先天性黑矇模型的方法 |
| JP7168814B1 (ja) | 2022-07-01 | 2022-11-09 | 東洋インキＳｃホールディングス株式会社 | 積層体の分離回収方法 |
| CN118453915A (zh) * | 2024-04-29 | 2024-08-09 | 中国医学科学院北京协和医院 | 一种针对rdh12突变的基因治疗药物 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| US6268213B1 (en) | 1992-06-03 | 2001-07-31 | Richard Jude Samulski | Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| US5869305A (en) | 1992-12-04 | 1999-02-09 | The University Of Pittsburgh | Recombinant viral vector system |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| DE69824859T2 (de) | 1997-04-14 | 2005-08-04 | Cell Genesys, Inc., Foster City | Methoden zur erhöhung der effizienz rekombinanter aav produkte |
| JP2001517454A (ja) | 1997-09-19 | 2001-10-09 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組換えアデノ随伴ウイルスの産生に有用な方法および細胞株 |
| EP1080218A1 (en) | 1998-05-27 | 2001-03-07 | University of Florida | Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient |
| DE69941905D1 (de) | 1998-11-10 | 2010-02-25 | Univ North Carolina | Virusvektoren und verfahren für ihre herstellung und verabreichung. |
| ES2308989T3 (es) | 1999-08-09 | 2008-12-16 | Targeted Genetics Corporation | Aumento de la expresion de una secuencia nucleotidica heterologa a partir de vectores viricos recombinantes que contienen una secuencia que forman pares de bases intracatenarios. |
| EP1286703B1 (en) | 2000-06-01 | 2009-08-05 | University Of North Carolina At Chapel Hill | Methods and compounds for controlled release of recombinant parvovirus vectors |
| WO2002082904A2 (en) | 2001-04-13 | 2002-10-24 | The Trustees Of The University Of Pennsylvania | Method of treating or retarding the development of blindness |
| NZ618298A (en) | 2001-11-13 | 2015-04-24 | Univ Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| PT2359869T (pt) | 2001-12-17 | 2019-04-16 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| WO2003104413A2 (en) | 2002-06-05 | 2003-12-18 | University Of Florida | Production of pseudotyped recombinant aav virions |
| WO2004058166A2 (en) | 2002-12-23 | 2004-07-15 | Vical Incorporated | Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| EP1486567A1 (en) | 2003-06-11 | 2004-12-15 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Improved adeno-associated virus (AAV) vector for gene therapy |
| EP2292780B1 (en) | 2003-09-30 | 2017-08-23 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| US7422840B2 (en) | 2004-11-12 | 2008-09-09 | E.I. Du Pont De Nemours And Company | Apparatus and process for forming a printing form having a cylindrical support |
| EP2359865B1 (en) | 2005-04-07 | 2013-10-02 | The Trustees of The University of Pennsylvania | Method of increasing the function of an AAV vector |
| JP4495210B2 (ja) | 2005-06-09 | 2010-06-30 | パナソニック株式会社 | 振幅誤差補償装置及び直交度誤差補償装置 |
| EP2007795B1 (en) | 2006-03-30 | 2016-11-16 | The Board Of Trustees Of The Leland Stanford Junior University | Aav capsid proteins |
| WO2009105690A2 (en) | 2008-02-21 | 2009-08-27 | Targeted Genetics Corporation | Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| US7561973B1 (en) | 2008-07-31 | 2009-07-14 | Dna Twopointo, Inc. | Methods for determining properties that affect an expression property value of polynucleotides in an expression system |
| US7561972B1 (en) | 2008-06-06 | 2009-07-14 | Dna Twopointo, Inc. | Synthetic nucleic acids for expression of encoded proteins |
| US20120172419A1 (en) * | 2009-09-15 | 2012-07-05 | Medical College Of Wisconsin Research Foundation Inc. | Reagents and methods for modulating cone photoreceptor activity |
| US9315825B2 (en) | 2010-03-29 | 2016-04-19 | The Trustees Of The University Of Pennsylvania | Pharmacologically induced transgene ablation system |
| SG183929A1 (en) | 2010-03-29 | 2012-10-30 | Univ Pennsylvania | Pharmacologically induced transgene ablation system |
| AU2011242527B2 (en) * | 2010-04-23 | 2016-05-19 | University Of Florida Research Foundation, Inc. | rAAV-guanylate cyclase compositions and methods for treating Leber's congenital amaurosis-1 (LCA1) |
| US9249425B2 (en) | 2011-05-16 | 2016-02-02 | The Trustees Of The University Of Pennslyvania | Proviral plasmids and production of recombinant adeno-associated virus |
| HK1206601A1 (en) * | 2012-04-02 | 2016-01-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
| NZ704275A (en) | 2012-07-11 | 2016-09-30 | Univ Florida | Aav-mediated gene therapy for rpgr x-linked retinal degeneration |
| US9719106B2 (en) | 2013-04-29 | 2017-08-01 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof |
| US8962449B1 (en) | 2013-07-30 | 2015-02-24 | Micron Technology, Inc. | Methods for processing semiconductor devices |
| US11098094B2 (en) * | 2013-11-20 | 2021-08-24 | Fondazione Telethon | Artificial DNA-binding proteins and uses thereof |
| JP6689249B2 (ja) * | 2014-03-17 | 2020-05-20 | アドヴェラム バイオテクノロジーズ， インコーポレイテッド | 錐体細胞における増強された遺伝子発現のための組成物および方法 |
| PE20170260A1 (es) | 2014-05-02 | 2017-04-12 | Genzyme Corp | Vectores de aav para la terapia genica de la retina y el snc |
| US10392622B2 (en) * | 2014-08-01 | 2019-08-27 | The Trustees Of The University Of Pennsylvania | Compositions and methods for self-regulated inducible gene expression |
| EP3452101A2 (en) * | 2016-05-04 | 2019-03-13 | CureVac AG | Rna encoding a therapeutic protein |
| IL264070B2 (en) | 2016-07-08 | 2023-03-01 | Univ Pennsylvania | Methods and preparations for the treatment of disorders and diseases involving rdh12 |
| WO2019099696A1 (en) | 2017-11-15 | 2019-05-23 | The Regents Of The University Of Michigan | Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies |
| TR2021022284A2 (tr) | 2021-12-31 | 2022-01-21 | T C Ueskuedar Ueniversitesi | Retinitis pigmentosa (rp) hastalığının tedavisinde kullanılmak üzere retinol dehidrojenaz 12 (rdh12) gen mutasyonlarına yönelik crıspr-pe sistemi. |
-
2017
- 2017-07-07 IL IL264070A patent/IL264070B2/en unknown
- 2017-07-07 KR KR1020197003500A patent/KR102526506B1/ko active Active
- 2017-07-07 RU RU2019103488A patent/RU2764920C2/ru active
- 2017-07-07 KR KR1020237013817A patent/KR102799528B1/ko active Active
- 2017-07-07 IL IL320533A patent/IL320533A/en unknown
- 2017-07-07 JP JP2019500531A patent/JP7101656B2/ja active Active
- 2017-07-07 IL IL297095A patent/IL297095B2/en unknown
- 2017-07-07 US US16/314,179 patent/US11197936B2/en active Active
- 2017-07-07 CN CN201780054628.1A patent/CN110191954B/zh active Active
- 2017-07-07 WO PCT/US2017/041122 patent/WO2018009814A1/en not_active Ceased
- 2017-07-07 CA CA3029646A patent/CA3029646A1/en active Pending
- 2017-07-07 AU AU2017292010A patent/AU2017292010B2/en active Active
- 2017-07-07 BR BR112019000171A patent/BR112019000171A2/pt not_active Application Discontinuation
- 2017-07-07 EP EP17824989.2A patent/EP3481958A4/en active Pending
-
2021
- 2021-11-10 US US17/523,492 patent/US20230037283A9/en active Pending
-
2022
- 2022-01-06 US US17/569,896 patent/US12419973B2/en active Active
- 2022-05-06 JP JP2022076693A patent/JP7572990B2/ja active Active
- 2022-08-26 US US17/822,533 patent/US20230009257A1/en active Pending
-
2023
- 2023-10-17 AU AU2023251411A patent/AU2023251411A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019524090A5 (OSRAM) | ||
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP2024015194A (ja) | アデノ随伴ウイルス変異キャプシドおよび血管新生の阻害のための使用 | |
| JP2022065003A (ja) | パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質 | |
| JP2021520203A (ja) | 減少した肝臓向性を有するＡＡＶ９とＡＡＶｒｈ７４とのハイブリッド組換えアデノ随伴ウイルス血清型 | |
| JP7572990B2 (ja) | Ｒｄｈ１２が関与する疾患及び疾病を治療する方法及び組成物 | |
| Korecki et al. | Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells | |
| US10849991B2 (en) | Gene therapy for the treatment of a disease of retinal cone cells | |
| JP2021507687A5 (OSRAM) | ||
| JP2020512822A5 (OSRAM) | ||
| Bemelmans et al. | A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina | |
| JP2024520815A (ja) | 神経線維腫性障害を処置するための組成物および方法 | |
| JP2018509154A5 (OSRAM) | ||
| US11077208B2 (en) | Wilson's disease gene therapy | |
| EP4509606A1 (en) | Nucleic acid construct for treating hereditary coagulation factor deficiency and use thereof | |
| US20170137480A1 (en) | Rpgr-ofr15 variant gene in the treatment of retinitis pigmentosa | |
| US20220389450A1 (en) | Vector system | |
| JP7637060B2 (ja) | Ａｋｔ経路を標的とする神経保護遺伝子療法 | |
| JP2024528997A (ja) | 放射線誘発性唾液機能低下を予防するためのａｑｐ１遺伝子療法 | |
| CN117940147A (zh) | Aqp1基因疗法预防辐射诱导的唾液功能减退 | |
| WO2024094009A1 (zh) | 用于目的基因的表达盒及其应用 | |
| WO2024257061A1 (en) | A hybrid dual aav vector system with splice enhancer elements for expression of large genes | |
| CN118256496A (zh) | 用于治疗视网膜色素变性的组合物和方法 | |
| HK40013460A (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 |